Literature DB >> 32071436

Target gene-independent functions of MYC oncoproteins.

Apoorva Baluapuri1, Elmar Wolf1, Martin Eilers2.   

Abstract

Oncoproteins of the MYC family are major drivers of human tumorigenesis. Since a large body of evidence indicates that MYC proteins are transcription factors, studying their function has focused on the biology of their target genes. Detailed studies of MYC-dependent changes in RNA levels have provided contrasting models of the oncogenic activity of MYC proteins through either enhancing or repressing the expression of specific target genes, or as global amplifiers of transcription. In this Review, we first summarize the biochemistry of MYC proteins and what is known (or is unclear) about the MYC target genes. We then discuss recent progress in defining the interactomes of MYC and MYCN and how this information affects central concepts of MYC biology, focusing on mechanisms by which MYC proteins modulate transcription. MYC proteins promote transcription termination upon stalling of RNA polymerase II, and we propose that this mechanism enhances the stress resilience of basal transcription. Furthermore, MYC proteins coordinate transcription elongation with DNA replication and cell cycle progression. Finally, we argue that the mechanism by which MYC proteins regulate the transcription machinery is likely to promote tumorigenesis independently of global or relative changes in the expression of their target genes.

Entities:  

Mesh:

Substances:

Year:  2020        PMID: 32071436      PMCID: PMC7611238          DOI: 10.1038/s41580-020-0215-2

Source DB:  PubMed          Journal:  Nat Rev Mol Cell Biol        ISSN: 1471-0072            Impact factor:   94.444


  114 in total

1.  Direct activation of RNA polymerase III transcription by c-Myc.

Authors:  Natividad Gomez-Roman; Carla Grandori; Robert N Eisenman; Robert J White
Journal:  Nature       Date:  2003-01-16       Impact factor: 49.962

2.  c-Myc is a universal amplifier of expressed genes in lymphocytes and embryonic stem cells.

Authors:  Zuqin Nie; Gangqing Hu; Gang Wei; Kairong Cui; Arito Yamane; Wolfgang Resch; Ruoning Wang; Douglas R Green; Lino Tessarollo; Rafael Casellas; Keji Zhao; David Levens
Journal:  Cell       Date:  2012-09-28       Impact factor: 41.582

3.  Polo-like Kinase-1 Regulates Myc Stabilization and Activates a Feedforward Circuit Promoting Tumor Cell Survival.

Authors:  Daibiao Xiao; Ming Yue; Hexiu Su; Ping Ren; Jue Jiang; Feng Li; Yufeng Hu; Haining Du; Hudan Liu; Guoliang Qing
Journal:  Mol Cell       Date:  2016-10-20       Impact factor: 17.970

4.  Deletion of Mnt leads to disrupted cell cycle control and tumorigenesis.

Authors:  Peter J Hurlin; Zi-Qiang Zhou; Kazuhito Toyo-oka; Sara Ota; William L Walker; Shinji Hirotsune; Anthony Wynshaw-Boris
Journal:  EMBO J       Date:  2003-09-15       Impact factor: 11.598

5.  Stabilization of N-Myc is a critical function of Aurora A in human neuroblastoma.

Authors:  Tobias Otto; Sebastian Horn; Markus Brockmann; Ursula Eilers; Lars Schüttrumpf; Nikita Popov; Anna Marie Kenney; Johannes H Schulte; Roderick Beijersbergen; Holger Christiansen; Bernd Berwanger; Martin Eilers
Journal:  Cancer Cell       Date:  2009-01-06       Impact factor: 31.743

6.  L-myc, a new myc-related gene amplified and expressed in human small cell lung cancer.

Authors:  M M Nau; B J Brooks; J Battey; E Sausville; A F Gazdar; I R Kirsch; O W McBride; V Bertness; G F Hollis; J D Minna
Journal:  Nature       Date:  1985 Nov 7-13       Impact factor: 49.962

7.  MYC Is a Major Determinant of Mitotic Cell Fate.

Authors:  Caroline Topham; Anthony Tighe; Peter Ly; Ailsa Bennett; Olivia Sloss; Louisa Nelson; Rachel A Ridgway; David Huels; Samantha Littler; Claudia Schandl; Ying Sun; Beatrice Bechi; David J Procter; Owen J Sansom; Don W Cleveland; Stephen S Taylor
Journal:  Cancer Cell       Date:  2015-07-13       Impact factor: 31.743

8.  The ConSurf-DB: pre-calculated evolutionary conservation profiles of protein structures.

Authors:  Ofir Goldenberg; Elana Erez; Guy Nimrod; Nir Ben-Tal
Journal:  Nucleic Acids Res       Date:  2008-10-29       Impact factor: 16.971

9.  The spliceosome is a therapeutic vulnerability in MYC-driven cancer.

Authors:  Tiffany Y-T Hsu; Lukas M Simon; Nicholas J Neill; Richard Marcotte; Azin Sayad; Christopher S Bland; Gloria V Echeverria; Tingting Sun; Sarah J Kurley; Siddhartha Tyagi; Kristen L Karlin; Rocio Dominguez-Vidaña; Jessica D Hartman; Alexander Renwick; Kathleen Scorsone; Ronald J Bernardi; Samuel O Skinner; Antrix Jain; Mayra Orellana; Chandraiah Lagisetti; Ido Golding; Sung Y Jung; Joel R Neilson; Xiang H-F Zhang; Thomas A Cooper; Thomas R Webb; Benjamin G Neel; Chad A Shaw; Thomas F Westbrook
Journal:  Nature       Date:  2015-09-02       Impact factor: 49.962

10.  BRCA2 Regulates Transcription Elongation by RNA Polymerase II to Prevent R-Loop Accumulation.

Authors:  Mahmud K K Shivji; Xavier Renaudin; Çiğdem H Williams; Ashok R Venkitaraman
Journal:  Cell Rep       Date:  2018-01-28       Impact factor: 9.423

View more
  62 in total

1.  A High-Throughput Chromatin Immunoprecipitation Sequencing Approach to Study the Role of MYC on the Epigenetic Landscape.

Authors:  Luca Fagnocchi; Alessio Zippo
Journal:  Methods Mol Biol       Date:  2021

2.  Circular RNAs With Efficacy in Preclinical In Vitro and In Vivo Models of Esophageal Squamous Cell Carcinoma.

Authors:  Ulrich H Weidle; Tatjana Sela; Ulrich Brinkmann; Jens Niewoehner
Journal:  Cancer Genomics Proteomics       Date:  2022 May-Jun       Impact factor: 4.069

Review 3.  MYC protein interactors in gene transcription and cancer.

Authors:  Diana Resetca; Cornelia Redel; Corey Lourenco; Peter Lin; Alannah S MacDonald; Roberto Ciaccio; Tristan M G Kenney; Yong Wei; David W Andrews; Maria Sunnerhagen; Cheryl H Arrowsmith; Brian Raught; Linda Z Penn
Journal:  Nat Rev Cancer       Date:  2021-06-29       Impact factor: 60.716

4.  Combined inhibition of Aurora-A and ATR kinase results in regression of MYCN-amplified neuroblastoma.

Authors:  Isabelle Roeschert; Evon Poon; Anton G Henssen; Heathcliff Dorado Garcia; Marco Gatti; Celeste Giansanti; Yann Jamin; Carsten P Ade; Peter Gallant; Christina Schülein-Völk; Petra Beli; Mark Richards; Mathias Rosenfeldt; Matthias Altmeyer; John Anderson; Angelika Eggert; Matthias Dobbelstein; Richard Bayliss; Louis Chesler; Gabriele Büchel; Martin Eilers
Journal:  Nat Cancer       Date:  2021-02-11

Review 5.  Ubiquitin-dependent regulation of transcription in development and disease.

Authors:  Kevin G Mark; Michael Rape
Journal:  EMBO Rep       Date:  2021-03-28       Impact factor: 8.807

6.  MYC promotes cancer progression by modulating m6 A modifications to suppress target gene translation.

Authors:  Gongwei Wu; Caixia Suo; Ying Yang; Shengqi Shen; Linchong Sun; Shi-Ting Li; Yingli Zhou; Dongdong Yang; Yan Wang; Yongping Cai; Nana Wang; Huafeng Zhang; Yun-Gui Yang; Jie Cao; Ping Gao
Journal:  EMBO Rep       Date:  2021-01-11       Impact factor: 8.807

7.  Ubiquitylation of MYC couples transcription elongation with double-strand break repair at active promoters.

Authors:  Theresa Endres; Daniel Solvie; Jan B Heidelberger; Valentina Andrioletti; Apoorva Baluapuri; Carsten P Ade; Matthias Muhar; Ursula Eilers; Seychelle M Vos; Patrick Cramer; Johannes Zuber; Petra Beli; Nikita Popov; Elmar Wolf; Peter Gallant; Martin Eilers
Journal:  Mol Cell       Date:  2021-01-15       Impact factor: 17.970

8.  MYC regulates ribosome biogenesis and mitochondrial gene expression programs through its interaction with host cell factor-1.

Authors:  Tessa M Popay; Jing Wang; Clare M Adams; Gregory Caleb Howard; Simona G Codreanu; Stacy D Sherrod; John A McLean; Lance R Thomas; Shelly L Lorey; Yuichi J Machida; April M Weissmiller; Christine M Eischen; Qi Liu; William P Tansey
Journal:  Elife       Date:  2021-01-08       Impact factor: 8.140

9.  MYC- and MIZ1-Dependent Vesicular Transport of Double-Strand RNA Controls Immune Evasion in Pancreatic Ductal Adenocarcinoma.

Authors:  Bastian Krenz; Anneli Gebhardt-Wolf; Carsten P Ade; Abdallah Gaballa; Florian Roehrig; Emilia Vendelova; Apoorva Baluapuri; Ursula Eilers; Peter Gallant; Luana D'Artista; Armin Wiegering; Georg Gasteiger; Mathias T Rosenfeldt; Stefan Bauer; Lars Zender; Elmar Wolf; Martin Eilers
Journal:  Cancer Res       Date:  2021-06-18       Impact factor: 12.701

Review 10.  Targeting the MYC Ubiquitination-Proteasome Degradation Pathway for Cancer Therapy.

Authors:  Xiao-Xin Sun; Yanping Li; Rosalie C Sears; Mu-Shui Dai
Journal:  Front Oncol       Date:  2021-06-11       Impact factor: 6.244

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.